CHUDIK SCIENTIFIC / COMPANY & LABORATORY
Clear information.
Better research decisions.
Explore our laboratory, understand analytical methods and find practical guidance for working with research materials.
THE SCIENTIFIC RECORD
Material. Method.
Result. Context.
A number becomes useful when it is connected to the right sample, a documented method and clearly stated limits.
EXPLORE CHUDIK SCIENTIFIC
A practical resource for your laboratory.
01 / THE COMPANY
About Chudik Scientific
Learn about our focus on laboratory supplies, research materials and documented analytical questions.
02 / THE LABORATORY
Testing & methods
Understand the role of HPLC/DAD and what different analytical measurements can support.
03 / THE LIBRARY
Research & findings
Read educational articles and learn how we present sample-specific findings.
FROM INFORMATION TO SELECTION
Understand the material before choosing it.
Guidance for laboratory work.
Product selection starts with the intended laboratory task, the specification and the supporting documentation. Our guides help explain the questions to ask.
The laboratory catalog at chudikscientific.org holds product details and customer inquiries. This site is the home for company information and educational articles.
LATEST ARTICLES
Notes from the research library.
MariTide and Tirzepatide: Why One Blocks GIP While the Other Activates It
MariTide blocks GIP signaling while tirzepatide activates it. Their molecular designs, clinical evidence and unresolved mechanisms explain the apparent contradiction.
After GLP-1 Treatment Stops: What Withdrawal Studies Actually Measure
Why a 14% weight increase and regaining two-thirds of a prior loss describe different measurements, and what withdrawal study designs can establish.
Why GLP-1 Weight Loss Plateaus Even When Treatment Continues
Explore why weight loss can slow during continued treatment, what a SURMOUNT analysis called a plateau, and how a mathematical model differs from clinical observations.
Do GLP-1 Drugs Have to Make You Feel Sick to Work?
Does nausea explain GLP-1 weight loss? Two semaglutide studies separate digestive symptoms, appetite, food intake and weight outcomes—and show where the evidence stops.
GLP-1, GIP and Glucagon: Why Two or Three Targets Aren’t a Strength Rating
A receptor map for semaglutide, tirzepatide and retatrutide, with the distinctions between binding, cellular response, mouse findings and human evidence.
Semaglutide vs Tirzepatide: What a Head-to-Head Trial Actually Shows
What SURMOUNT-5’s 72-week results reveal about average weight and waist changes, and why the tested treatments, population and safety evidence matter.
WORK WITH CHUDIK SCIENTIFIC
Start with a clear question.
Discuss a research material, an analytical inquiry or a laboratory supply requirement.